
Chemical and Pharmaceutical Bulletin p. 782 - 786 (1998)
Update date:2022-07-30
Topics:
Martin-Martinez, Mercedes
Ballaz, Santiago
Latorre, Miriam
Herranz, Rosario
Garcia-Lopez, M. Teresa
Cenarruzabeitia, Edurne
Del Rio, Joaquin
Gonzalez-Muniz, Rosario
In order to find new classes of non-peptide cholecystokinin (CCK) ligands, the conformational restriction of a series of weak 3- oxoindolizidine-based CCK antagonists has been both decreased and increased. This tactic yielded a series of monocyclic 2-oxopyrrolidine derivatives 4 with selectivity for CCK-A or CCK-B receptors and with slightly improved binding affinity at the CCK-A receptor subtype with respect to the model 3- oxoindolizidines. In contrast, the incorporation of the Trp residue at the secondary amino group of a pyrrolo[1,2-a]pyrazine template 5, involving a drastic restriction in the conformational flexibility of the molecule, resulted in a series of bicyclic derivatives that did not bind to CCK receptors at concentrations up to 10-5 M.
View MoreGuangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Contact:13120882795;+86-21-34621078;+86-021-31122318
Address:Suite 2,No.2715 Longwu Road
Contact:18669908765
Address:Zibo City, Shandong Province, P.R.China
Contact:21-7631221 15884421033
Address:326 Science and technology,Shanghai,China
Changsha Yihai Chemical Technology Co.,ltd
website:http://www.cs-yihai.com/
Contact:0731- 85620465
Address:Room 23005, unit 2, the northern building of Xiangsong international building , NO.259 Shaoshan Road , Changsha , Hunan, China.(mainland)
Doi:10.1080/00958972.2010.548862
(2011)Doi:10.1039/c0cc04677a
(2011)Doi:10.1021/jo980541v
(1998)Doi:10.1021/acschemneuro.6b00181
(2017)Doi:10.1016/j.jorganchem.2016.12.013
(2017)Doi:10.1021/jm000286i
(2000)